Acrivon AB
559152-0944ActiveDeveloping targeted cancer therapies using proprietary proteomics platform.
Oversikt
- 10–19
- Ansatte
- 20–50mill SEK
- Omsetning
- 2018
- Grunnlagt
Nøkkelbeslutningstakere
Peter Blume-Jensen
CEO, President, Founder Chairperson
David Proia
SVP, Biology and Drug Discovery
Eric Devroe
Chief Operating Officer
Ivana Magovčević-Liebisch
Director
+21 flere kontakter i Funnelfeedr
Beskrivelse
Acrivon Therapeutics is a clinical-stage oncology company focused on developing targeted therapies to improve patient lives. They utilize their proprietary Acrivon Predictive Precision Proteomics (AP3) platform, which moves beyond traditional genomics. This platform generates unique OncoSignature co...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559152094401
Beslutningstakere
25 kontakter i FunnelfeedrPeter Blume-Jensen
CEO, President, Founder Chairperson
David Proia
SVP, Biology and Drug Discovery
Eric Devroe
Chief Operating Officer
Ivana Magovčević-Liebisch
Director
Charles (Chuck) Baum
Director
Katharine Peterson
VP, Finance and Chief Accounting Officer
John van Duzer
SVP, CMC
Mansoor Raza Mirza
Chief Medical Officer
Joon Jung
SVP and Head, Data Science
Mary-Alice Miller
Chief Legal Officer
Michail Shipitsin
VP, Biomarker Development
Rajshree Kandadai
VP, Business Development
Adam D. Levy
Chief Financial Officer
Derek DiRocco
Director
Bruce Close
VP, Quality and Compliance
Praveen Marapaka
SVP, Global Regulatory Affairs
Jesper Olsen
Academic Co-Founder, Head of Phosphoproteomics
Kristina Masson
Co-Founder, EVP, Business Operations, Site Head, Director
Monica Phadnis
SVP, Clinical Operations
Sharon Shacham
Director
Christina Scherer
VP and Head, Early Portfolio Management
Erick Gamelin
Chief Development Officer
Santhosh Palani
Director
Michael Tomsicek
Director
Virna Schuck
VP of Clinical Pharmacology
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrAkiram Therapeutics AB
Pioneering targeted radioimmunotherapy to treat incurable solid tumors effectively.
MyCural Therapeutics AB
10–19 ansatteDeveloping novel small molecule therapies targeting the MYC oncoprotein.
APIM THERAPEUTICS AS
Biotech company developing novel peptide therapeutics targeting cancer cell survival mechanisms.
Biovica International AB
10–19 ansatteDeveloping blood tests to monitor cancer treatment efficacy.
Biovica Services AB
Developing blood tests to monitor cancer treatment efficacy.
Utforsk mer
Spørsmål om Acrivon AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo